Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sofosbuvir-Based Regimens in Egyptian HCV Patients
NCT02992457Phase 4Completed
- Sponsor
- Tanta University
- Start
- Jan 2015
- Primary completion
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of sofosbuvir in hepatitis C (HCV) (7 arms), sponsored by Tanta University. Primary endpoint: Sustained Virological Response at 2 months. Started Jan 2015; status: completed.
02
Drugs
sofosbuvir
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT02992457.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02992457.